All PlansAdministrativeMedium impact
Voluntary nationwide recall: Potassium (Bluepoint – June)
UPMC Health Plan·Pharmacy, Cardiology, Internal Medicine +2 more·Pharmacy
Effective date
Jun 25, 2024
We identified it
Aug 7, 2026
Summary
BluePoint Laboratories is recalling 21 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K due to dissolution failure that may cause dangerous high potassium levels and cardiac complications. The billing team must alert providers and patients to verify medication batch numbers and coordinate with pharmacies and physicians regarding affected prescriptions and potential claim adjustments for recalled medication.
Action Required
Immediately: Clinical and billing teams must coordinate to identify patients who may have received recalled Potassium Chloride batches. Providers should contact patients to verify medication batch numbers against the 21 recalled batches. Billing team must flag any claims associated with recalled batches for potential adjustment or reversal pending physician guidance. Direct providers to contact Sedgwick at 1-855-695-8564 or visit the FDA website for complete batch information. Do not process new claims for recalled batches without provider confirmation of non-recalled alternatives. Maintain documentation of all communications and adjustments for compliance purposes.